NDC 68001-661 – Dasatinib
Dasatinib 50 mg/1 · Tablet, Film Coated · Oral
Product NDC68001-661
Product details
- Brand name
- Dasatinib
- Generic name
- Dasatinib
- Labeler
- BluePoint Laboratories
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA217217
- Marketed since
- October 30, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Dasatinib 50 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 68001-661-06 | 60 TABLET, FILM COATED in 1 BOTTLE (68001-661-06) | Oct 30, 2025 |
Other Dasatinib products
- 62332-686 Dasatinib 70 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-684 Dasatinib 20 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-688 Dasatinib 100 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-687 Dasatinib 80 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-685 Dasatinib 50 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-689 Dasatinib 140 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 46708-687 Dasatinib 80 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 46708-688 Dasatinib 100 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 46708-686 Dasatinib 70 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 46708-689 Dasatinib 140 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 46708-685 Dasatinib 50 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 46708-684 Dasatinib 20 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited